These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26118348)

  • 1. Modification of a PAMPA model to predict passive gastrointestinal absorption and plasma protein binding.
    Bujard A; Voirol H; Carrupt PA; Schappler J
    Eur J Pharm Sci; 2015 Sep; 77():273-8. PubMed ID: 26118348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique.
    Bujard A; Sol M; Carrupt PA; Martel S
    Eur J Pharm Sci; 2014 Oct; 63():36-44. PubMed ID: 25008117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDM-PAMPA to predict gastrointestinal absorption, binding percentage, equilibrium and kinetics constants with human serum albumin and using 2 end-point measurements.
    Bujard A; Petit C; Carrupt PA; Rudaz S; Schappler J
    Eur J Pharm Sci; 2017 Jan; 97():143-150. PubMed ID: 27816629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    J Pharm Sci; 2012 Feb; 101(2):530-40. PubMed ID: 22052653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the Passive Intestinal Absorption of Medicinal Plant Extract Constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA).
    Petit C; Bujard A; Skalicka-Woźniak K; Cretton S; Houriet J; Christen P; Carrupt PA; Wolfender JL
    Planta Med; 2016 Mar; 82(5):424-31. PubMed ID: 26872320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration.
    Singh SS; Mehta J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):108-16. PubMed ID: 16567134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB.
    Di L; Kerns EH; Bezar IF; Petusky SL; Huang Y
    J Pharm Sci; 2009 Jun; 98(6):1980-91. PubMed ID: 18837012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood-brain barrier penetration and binding to human serum albumin.
    Pérez DI; Pistolozzi M; Palomo V; Redondo M; Fortugno C; Gil C; Felix G; Martinez A; Bertucci C
    Eur J Pharm Sci; 2012 Apr; 45(5):677-84. PubMed ID: 22306656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin-PAMPA: a new method for fast prediction of skin penetration.
    Sinkó B; Garrigues TM; Balogh GT; Nagy ZK; Tsinman O; Avdeef A; Takács-Novák K
    Eur J Pharm Sci; 2012 Apr; 45(5):698-707. PubMed ID: 22326705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters.
    Mensch J; Jaroskova L; Sanderson W; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Int J Pharm; 2010 Aug; 395(1-2):182-97. PubMed ID: 20635475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability of olmesartan medoxomil from lipid based and suspension formulations using an optimized HDM-PAMPA model.
    Komesli Y; Karasulu E
    Pharm Dev Technol; 2022 Jul; 27(6):749-757. PubMed ID: 35972198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAMPA study of the temperature effect on permeability.
    Vizserálek G; Balogh T; Takács-Novák K; Sinkó B
    Eur J Pharm Sci; 2014 Mar; 53():45-9. PubMed ID: 24361474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2006 Jun; 49(13):3948-54. PubMed ID: 16789751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.